# US 2003/0077795 A1 · Cytochrome P450 monooxygenase and NADPH Cytochrome P450 oxidoreductase genes and proteins related to the omega hydroxylase complex of candida tropicals and methods relating thereto

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2003/0077795 A1
- Document ID: US20030077795A1
- Status: Published application
- Kind: A1
- Application number: 09/976,800
- Filed: 2001-10-12
- Published: 2003-04-24
- Earliest claimed: 1999-03-10
- Inventors: C. Ron Wilson; David L. Craft; L. Dudley Eirich; Mark Eshoo; Krishna M. Madduri; Cathy A. Cornett; Alfred A. Brenner; Maria Tang; John C. Loper; Martin Gleeson
- Web page: https://patentgrep.com/patent/US20030077795A1

## CPC

- C12N 9/0042: {NADPH-cytochrome P450 reductase (1.6.2.4)}
- C07K 14/40: from Candida
- C12N 9/0071: {acting on paired donors with incorporation of molecular oxygen (1.14)}
- C12N 9/0077: {with a reduced iron-sulfur protein as one donor (1.14.15)}
- C12P 7/44: Polycarboxylic acids
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}

## Abstract

Novel genes have been isolated which encode cytochrome P450 and NADPH reductase enzymes of the co-hydroxylase complex of C. tropicalis 20336. Vectors including these genes, transfected host cells and transformed host cells are provided. Methods of producing of cytochrome P450 and NADPH reductase enzymes are also provided which involve transforming a host cell with a gene encoding these enzymes and culturing the cells. Methods of increasing the production of a dicarboxylic acid and methods of increasing production of the aforementioned enzymes are also provided which involve increasing in the host cell the number of genes encoding these enzymes. A method for discriminating members of a gene family by quantifying the expression of genes is also provided.

## Claims

### Claim 1

Isolated nucleic acid encoding a CYP52A2B protein having the amino acid sequence set forth in SEQ ID NO: 97.

### Claim 2

Isolated nucleic acid comprising a coding region defined by nucleotides 1072-2640 as set forth in SEQ ID NO: 87.

### Claim 3 (depends on 2)

Isolated nucleic acid according to claim 2 comprising the nucleotide sequence as set forth in SEQ ID NO: 87.

### Claim 4

A vector comprising a nucleotide sequence encoding CYP52A2B protein including an amino acid sequence as set forth in SEQ ID NO: 97.

### Claim 5 (depends on 4)

A vector according to claim 4 wherein the nucleotide sequence is set forth in nucleotides 1072-2640 of SEQ ID NO: 87.

### Claim 6 (depends on 4)

A vector according to claim 4 wherein the vector is selected from the group consisting of plasmid, phagemid, phage and cosmid.

### Claim 7 (depends on 1)

A host cell transfected or transformed with the nucleic acid of claim 1.

### Claim 8 (depends on 7)

A host cell according to claim 7 wherein the host cell is a yeast cell.

### Claim 9 (depends on 8)

A host cell according to claim 8 wherein the yeast cell is a Candida sp.

### Claim 10 (depends on 9)

A host cell according to claim 9 wherein the Candida sp. is Candida tropicalis.

### Claim 11 (depends on 10)

A host cell according to claim 10 wherein the Candida tropicalis is Candida tropicalis 20336.

### Claim 12 (depends on 11)

A host cell according to claim 11 wherein the Candida tropicalis is H5343 ura−.

### Claim 13

A method of producing a CYP52A2B protein including an amino acid sequence as set forth in SEQ ID NO: 97 comprising:
a) transforming a suitable host cell with a DNA sequence that encodes the protein having the amino acid sequence as set forth in SEQ ID NO: 97; and
b) culturing the cell under conditions and in media favoring the expression of the protein.

### Claim 14 (depends on 13)

The method according to claim 13 wherein the step of culturing the cell comprises adding an organic substrate to the media containing the cell.

### Claim 15

A method for increasing production of a dicarboxylic acid comprising:
a) providing a host cell having a naturally occurring number of CYP52A2B genes;
b) increasing, in the host cell, the number of CYP52A2B genes which encode a CYP52A2B protein having the amino acid sequence as set forth in SEQ ID NO: 97;
c) culturing the host cell in media containing an organic substrate which upregulates the CYP52A2B gene, to effect increased production of dicarboxylic acid.

### Claim 16

A method for increasing the production of a CYP52A2B protein having an amino acid sequence as set forth in SEQ ID NO: 97 comprising:
a) transforming a host cell having a naturally occurring amount of CYP52A2B protein to increase the copy number of CYP52A2B genes that encode the CYP52A2B protein having the amino acid sequence as set forth in SEQ ID NO: 97; and
b) culturing the cell and thereby increasing expression of the protein as compared to an untransformed host cell.
